上市一年后,毛戈平家族等6人拟减持逾3%股份,或将套现13亿

Core Viewpoint - The announcement by Maogeping (01318.HK) regarding the planned share reduction by its major shareholders has attracted significant market attention, with a total of up to 17.2 million shares, representing 3.51% of the company's issued shares, to be sold within six months [1][5]. Group 1: Shareholder Information - The shareholders involved in the reduction include Maogeping, his spouse Wang Liqun, and his sisters, along with a core executive, Song Hongquan [2][3]. - The reason for the share reduction is stated as personal financial needs, with proceeds intended for investments in the beauty industry and personal living improvements [5]. Group 2: Market Reaction - Despite the planned share reduction, Maogeping's stock price increased by 7.26% on January 7, closing at 87.95 HKD per share, with a total market capitalization of 431 billion HKD [6]. Group 3: Company Background and Performance - Maogeping's journey in the capital market has been tumultuous, with multiple attempts at IPO since 2016, culminating in a successful listing on the Hong Kong Stock Exchange on December 10, 2024, at an issue price of 29.80 HKD per share [7][8]. - The company has two main beauty brands, MAOGEPING and Zhi Ai Zhong Sheng, and has expanded into makeup artistry training, with nine institutions established nationwide by mid-2025 [8]. - Recent financial performance shows steady growth, with total revenue increasing from 15.77 billion CNY in 2021 to 28.86 billion CNY in 2023, reflecting a compound annual growth rate (CAGR) of 35.3%, and net profit rising from 3.31 billion CNY to 6.64 billion CNY during the same period, with a CAGR of 41.6% [8]. - In its first year post-IPO (2024), the company achieved revenue of 38.85 billion CNY, a year-on-year increase of 34.6%, and a net profit of 8.81 billion CNY, up 32.8% [9]. - For the first half of 2025, the company reported revenue of 25.88 billion CNY, a 31.3% increase year-on-year, and a net profit of 6.70 billion CNY, reflecting a 36.1% growth [10].